| 归创通桥 |
宁波保税区帖斯以股权投资合伙企业（有限合伙） |
增持 |
19298911 |
1929.89万股 |
0.10% |
好仓 |
2021-07-05 |
| 归创通桥 |
赣州提坦股权投资合伙企业（有限合伙） |
增持 |
19298911 |
1929.89万股 |
0.10% |
好仓 |
2021-07-05 |
| 归创通桥 |
Ourea Biotech HK Limited |
增持 |
19298911 |
1929.89万股 |
0.10% |
好仓 |
2021-07-05 |
| 归创通桥 |
Ourea Biotech HK Limited |
增持 |
9963681 |
996.37万股 |
0.08% |
好仓 |
2021-07-05 |
| 归创通桥 |
Homehealth Investment Limited家健投资有限公司 |
增持 |
9963681 |
996.37万股 |
0.08% |
好仓 |
2021-07-05 |
| 归创通桥 |
Highlight Medical Limited |
增持 |
9963681 |
996.37万股 |
0.08% |
好仓 |
2021-07-05 |
| 归创通桥 |
Five Investment Limited |
增持 |
19298911 |
1929.89万股 |
0.10% |
好仓 |
2021-07-05 |
| 归创通桥 |
Morgan Stanley International Limited |
增持 |
10056009 |
1005.60万股 |
0.08% |
好仓 |
2021-07-05 |
| 归创通桥 |
赵中 |
增持 |
97564919 |
9756.49万股 |
0.48% |
好仓 |
2021-07-05 |
| 归创通桥 |
OrbiMed Advisors IV Limited |
增持 |
25335535 |
2533.55万股 |
0.21% |
好仓 |
2021-07-05 |
| 归创通桥 |
OrbiMed Asia GP IV, L.P. |
增持 |
25335535 |
2533.55万股 |
0.21% |
好仓 |
2021-07-05 |
| 归创通桥 |
OrbiMed Asia Partners IV, L.P. |
增持 |
25335535 |
2533.55万股 |
0.21% |
好仓 |
2021-07-05 |
| 归创通桥 |
OAP IV (HK) Limited |
增持 |
25335535 |
2533.55万股 |
0.21% |
好仓 |
2021-07-05 |
| 归创通桥 |
卫娜 |
增持 |
97564919 |
9756.49万股 |
0.48% |
好仓 |
2021-07-05 |
| 赏之味 |
邓庆治 |
减持 |
-40000000 |
30125.00万股 |
0.60% |
好仓 |
2021-07-05 |
| 赏之味 |
邓振豪 |
减持 |
-40000000 |
30125.00万股 |
0.60% |
好仓 |
2021-07-05 |
| 归创通桥 |
AIHC Master Fund |
增持 |
8206796 |
820.68万股 |
0.07% |
好仓 |
2021-07-05 |
| 归创通桥 |
Schroder International Selection Fund -Greater China Fund |
增持 |
9003500 |
900.35万股 |
0.07% |
好仓 |
2021-07-05 |
| 复宏汉霖 |
曾琪铃 |
减持 |
-15876694 |
0.00万股 |
0.00% |
好仓 |
2021-07-05 |
| 白马户外媒体 |
Decaux Jean-Sebastien |
增持 |
58774450 |
53653.00万股 |
0.99% |
好仓 |
2021-07-03 |
